Communiqués ViaDerma, Inc.

Actions

VDRM

US92555K1016

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets Autres places de cotation 19:45:59 03/06/2026			Varia. 5j.	Varia. 1 janv.
0,000300 ^USD	-25,00%		-25,00%	+50,00%

21/01/25	ViaDerma, Inc. renforce son expansion mondiale avec un nouveau bureau à Dubaï et progresse vers l'enregistrement de son produit en Inde	CI
13/08/24	ViaDerma, Inc. annonce le début du processus d'enregistrement au Kenya, en Namibie et en Tanzanie en vue d'une expansion stratégique en Afrique de l'Est et en Afrique australe	CI

Communiqués

16/07/25	ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes	AQ
04/06/25	ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance	AQ
21/01/25	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	AQ
10/12/24	ViaDerma Announces Significant 2024 Achievements and International Expansion	AQ
03/10/24	ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth	AQ
10/09/24	ViaDerma Completes First Shipment of 500,000 Units to Nigeria	AQ
13/08/24	ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria	AQ
01/08/24	ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires	AQ
06/06/24	ViaDerma Provides Highlights of Quarterly Financial Report	AQ
24/10/23	ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More	AQ
07/07/23	ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More	AQ
06/07/23	ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More	AQ
16/03/23	ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product	AQ
08/03/23	ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product	AQ
02/03/23	ViaDerma Provides an Update on Current & Future Business Activities	AQ
12/01/23	ViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth Online	AQ
12/01/23	ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development	AQ
15/09/22	ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products	AQ
22/06/22	ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products	AQ
31/03/22	ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year	AQ
30/03/22	ViaDerma : Annual Report	PU
21/12/21	ViaDerma : Attorney Letter with Respect to Current Information	PU
04/10/21	ViaDerma : Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra	AQ
24/08/21	ViaDerma, Inc. Files Amended Financial Statements	GL
24/06/21	ViaDerma, Inc. Provides Updates on Current Business Activities	GL